SpaceX and OpenAI IPOs Could Signal a Market Top
Historic U.S. equity issuance records preceded the crashes of 1929 and 2000. Some analysts warn the IPO pipeline may be flashing a similar warning.
Markets have a long memory, even when investors don't. The two prior peaks in U.S. equity issuance — 1929 and 2000 — each preceded devastating market collapses, and a growing chorus of analysts is now pointing to the swelling IPO pipeline, headlined by potential offerings from SpaceX and OpenAI, as a potential echo of those historic excess moments.
The pattern is worth understanding structurally. When private companies of extraordinary valuation finally move toward public markets, they often do so at the precise moment when retail and institutional appetite for risk is at its most stretched. The companies themselves are not the cause of a crash — rather, their arrival signals that the machinery of capital formation has reached a fever pitch that historically precedes sharp reversions.
Read more Ric Edelman: Crypto's Real Growth Story Isn't the Price →
SpaceX and OpenAI represent two of the most closely watched private companies in the world, each carrying valuations that dwarf most publicly traded peers. Should either — or both — pursue public listings, the sheer volume of new equity supply entering the market could test absorption capacity in ways not seen in decades. That supply shock, layered on top of already elevated valuations across the broader market, is what concerns strategists who see a 40% correction as a plausible tail risk.
The comparison to 1929 and 2000 is not meant to be alarmist in isolation, but it carries analytical weight precisely because those episodes shared a common architecture: transformative technology narratives, surging issuance, and widespread conviction that traditional valuation frameworks no longer applied. The AI investment supercycle has generated remarkably similar rhetoric. Whether history rhymes or merely whispers here remains an open question — but the setup, at minimum, warrants disciplined scrutiny from anyone with significant equity exposure.
Continue reading at MarketWatch.com
